See All Slides - tctmd.com

Slides

Presentation TVT 2013

Baseline Frailty Status of the "Extreme Risk" Patients in the US CoreValve Trial

Presenter: Jeffrey Popma

June 12, 2013

Presentation TVT 2013

Taking Strokes Seriously: Definitions (VARC 2), Stroke Grading Scores, Study Endpoints, Neuroimaging, and Neurocognitive Function

Presenter: Martin Leon

June 12, 2013

Presentation TVT 2013

New Sheath Technologies for Transfemoral Access: Advantages and Limitations

Presenter: Vasilis Babaliaros

June 12, 2013

Presentation TVT 2013

Risk Profiling Schemes Used in the US CoreValve Trial

Presenter: Steven Yakubov

June 12, 2013

Presentation

Adoption of Radial Access and Comparison of Outcomes to Femoral Access in PCI

Presenter: 220092|David Feldman

June 11, 2013

Presentation

CRISP: Remote Ischemic Preconditioning Improves Outcome at 6 Years After Elective PCI

Presenter: 212604|Will Davies

June 11, 2013

Presentation

Efficacy and Safety of Rivaroxaban in Patients with Heart Failure and Nonvalvular A-Efficacy and Safety of Rivaroxaban in Patients with Heart Failure and Nonvalvular A-fibfib

Presenter: Sean van Diepen

June 10, 2013

Presentation

OCT Analysis in Patients with Very Late Stent Thrombosis

Presenter: S-J Kang

June 10, 2013

Presentation TCT Russia 2013

PFO Closure: A Critical Overview of Recent Data

Presenter: Eustaquio Onorato

June 09, 2013

Presentation TCT Russia 2013

Aortic Valve Dilatation, TAVR Performance and Clinical Outcomes

Presenter: H?l?ne Eltchaninoff

June 09, 2013

Advertisement

Slides

Baseline Frailty Status of the "Extreme Risk" Patients in the US CoreValve Trial

Taking Strokes Seriously: Definitions (VARC 2), Stroke Grading Scores, Study Endpoints, Neuroimaging, and Neurocognitive Function

New Sheath Technologies for Transfemoral Access: Advantages and Limitations

Risk Profiling Schemes Used in the US CoreValve Trial

Adoption of Radial Access and Comparison of Outcomes to Femoral Access in PCI

CRISP: Remote Ischemic Preconditioning Improves Outcome at 6 Years After Elective PCI

Efficacy and Safety of Rivaroxaban in Patients with Heart Failure and Nonvalvular A-Efficacy and Safety of Rivaroxaban in Patients with Heart Failure and Nonvalvular A-fibfib

OCT Analysis in Patients with Very Late Stent Thrombosis

PFO Closure: A Critical Overview of Recent Data

Aortic Valve Dilatation, TAVR Performance and Clinical Outcomes

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content